Issue 20, 1997

Design, synthesis and pharmacological evaluation of active pyrrole based, nonpeptidic analogues of neurotensin(8-13)

Abstract

We report the design, synthesis and pharmacological analysis of pyrrole based, nonpeptidic analogues of neurotensin(8-13) for testing further our reported multiple template approach to developing nonpeptidic mimetics of neuropeptides and for developing nonpeptidic mimetics of neurotensin(8-13) as potential drug candidates for the treatments of neuropsychiatric diseases such as schizophrenia and Parkinson’s disease. Three newly synthesized pyrrole analogues (mimics-4, -5 and -6) designed by the multiple template approach have been found to be more active in binding to the neurotensin receptor than the previously reported indole based mimics-1 and -2, which are a partial nonpeptidic antagonist and an agonist of neurotensin(8-13), respectively. The results support the theory of the multiple template approach and provide insights into the rational design of more potent neurotensin mimetics and into the library design for rational screening for effective nonpeptide compounds by combinatorial chemistry.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 1, 1997, 2997-3004

Design, synthesis and pharmacological evaluation of active pyrrole based, nonpeptidic analogues of neurotensin(8-13)

F. Hong, J. Zaidi, Y. Pang, B. Cusack and E. Richelson, J. Chem. Soc., Perkin Trans. 1, 1997, 2997 DOI: 10.1039/A703319B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements